Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives "ESH-CHL-SHOT"


Phase 4 Results N/A

Summary of Purpose

Stroke is one of the major causes not only of mortality, but of disease burden worldwide, because of residual disability and cognitive decline. Although blood pressure lowering has been clearly shown to be the most effective means for primary and secondary prevention of stroke, the systolic blood pressure (SBP) levels to achieve by treatment in order to optimize prevention results are unknown, and whether SBP...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 6 April 2018.

1 Apr 2013 20 Mar 2012 1 Sep 2018 1 Nov 2018 1 Apr 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Factorial Assignment